Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Statins Can Save Your Eyes

MP3 WAV

  • Millions of Americans take statins, such as Lipitor and Zocor, which are cholesterol-lowering drugs. Along with preventing heart disease, these drugs may have an added benefit of keeping someone from going blind.

    A large study confirms anecdotes that statins prevent glaucoma, a common eye condition in people over forty. Yet, about half of those with glaucoma don't know they have it.

    Glaucoma develops when pressure slowly increases in the eye from a fluid build-up. Normally, a small amount of fluid is produced and drained daily to nourish parts of the eye that do not have blood vessels and maintain the proper amount of pressure between the various parts of the eye.

    But with glaucoma, the fluid does not drain and eeventually the person can't see as well or at all when the optic nerve is damaged. That's the bundle of nerves carrying information from the retina to the brain.

    The new study looked at 300,000 who've been on statins for two years to control their cholesterol. They have a nearly 10% lower risk of developing the most common form of glaucoma, open angle glaucoma. Also, the drugs work best in the early stages of the disease.

    It is not clear how statins do this. The drugs may improve blood flow to the optic nerve and retinal nerve cells, and help drain the aqueous fluid to reduce pressure in the eye.

    People most at risk for glaucoma are African Americans and Hispanics, diabetics, people over sixty, and those with a family history. Once glaucoma robs their sight, it is irreversible. But this can be easily avoided by yearly visits to the ophthalmologist along with a visit to your family doctor.

More Information

Reduced Glaucoma Risk Found in Patients Who Take Statins
ScienceDaily — "People who take statins to reduce their risk of cardiovascular disease are less likely to be diagnosed with the most common form of glaucoma, according to a nationwide study of more than 300,000 patients. A University of Michigan School of Medicine research team, directed by Joshua Stein, MD, MS, found that the risk for glaucoma was reduced by eight percent in patients who took statins continuously for two years, compared with patients who did not take statins."

How Glaucoma Affects the Optic Nerve
Short, informative article from the Glaucoma Research Foundation

Glaucoma
Info on glaucoma from the National Institutes of Health's MedlinePlus website

Two individuals wearing headphones stand in a recording booth, speaking into microphones with a music stand holding printed pages between them.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.